IGM Biosciences Inc (IGMS)

Currency in USD
1.28
-0.02(-1.54%)
Closed·
After Hours
1.280.00(0.00%)
·
IGMS Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 5 days
Fair Value
Day's Range
1.251.30
52 wk Range
0.9222.50
Key Statistics
Prev. Close
1.28
Open
1.3
Day's Range
1.25-1.3
52 wk Range
0.92-22.5
Volume
736.39K
Average Volume (3m)
601.9K
1-Year Change
-84.74%
Book Value / Share
1.68
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IGMS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.12
Downside
-12.23%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

IGM Biosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

IGM Biosciences Inc Company Profile

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.

IGM Biosciences Inc SWOT Analysis


Autoimmune Pivot
IGM Biosciences shifts focus to autoimmune diseases, streamlining its pipeline and preserving capital for key development programs in a growing market
Imvotamab's Potential
Explore the promise of IGM's lead candidate in treating rheumatoid arthritis and lupus, with topline results expected by mid-2025
Market Opportunity
Delve into IGM's positioning to capture a share of the $1.5+ billion inflammation and immunology market by 2025
Analyst Perspectives
Discover varied analyst views on IGM's future, with price targets ranging from $9 to $48, reflecting both optimism and caution
Read full SWOT analysis

Compare IGMS to Peers and Sector

Metrics to compare
IGMS
Peers
Sector
Relationship
P/E Ratio
−1.4x−1.2x−0.5x
PEG Ratio
−0.02−0.060.00
Price/Book
0.8x2.3x2.6x
Price / LTM Sales
0.5x10.1x3.3x
Upside (Analyst Target)
−12.2%292.9%42.8%
Fair Value Upside
Unlock21.2%6.5%Unlock

Analyst Ratings

0 Buy
4 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 1.12
(-12.23% Downside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.75 / -0.352
Revenue / Forecast
499.50K / 3.36M
EPS Revisions
Last 90 days

IGMS Income Statement

People Also Watch

33.30
BMNR
+6.97%
16.75
SRPT
-2.05%
0.532
WINT
-8.59%
5.7300
BGLC
-13.70%

FAQ

What Stock Exchange Does IGM Biosciences Trade On?

IGM Biosciences is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for IGM Biosciences?

The stock symbol for IGM Biosciences is "IGMS."

What Is the IGM Biosciences Market Cap?

As of today, IGM Biosciences market cap is 77.17M.

What Is IGM Biosciences's Earnings Per Share (TTM)?

The IGM Biosciences EPS (TTM) is -0.87.

When Is the Next IGM Biosciences Earnings Date?

IGM Biosciences will release its next earnings report on 10 Aug 2025.

From a Technical Analysis Perspective, Is IGMS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has IGM Biosciences Stock Split?

IGM Biosciences has split 0 times.

How Many Employees Does IGM Biosciences Have?

IGM Biosciences has 16 employees.

What is the current trading status of IGM Biosciences (IGMS)?

As of 06 Aug 2025, IGM Biosciences (IGMS) is trading at a price of 1.28, with a previous close of 1.28. The stock has fluctuated within a day range of 1.25 to 1.30, while its 52-week range spans from 0.92 to 22.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.